Today, Koneksa presented an abstract validating the use of remote measurements for patients with asthma.
On May 14 and 15, Koneksa CEO Chris Benko will present as part of “Wearable Technology – Challenges and Opportunities,” an industry program held by the European Bioinformatics Institute (EMBL-EBI).
I am fortunate to have the opportunity to travel to multiple site initiation visits and trainings for clinical research studies each year. Meeting with the incredibly dedicated study teams is an invaluable experience as I am able to hear from the people who support the front line of clinical research. During a recent training, I sat down with a research coordinator who seemed to be stretched very thin. Noticing this, we took a step back to talk through her hesitations.
Chris Benko first joined Merck when he was but a lad of eighteen, rising through the ranks in HR and talent management to become one of the youngest VPs in the history of the organization, at the age of 34.
But instead of continuing his ascending career into the senior ranks of biopharma, Chris opted instead to scratch the entrepreneurial itch and, after several years in Merck venture capital group, he founded a new company and left Merck to run it.
2016 has been an exciting year of growth and change at Koneksa. Our customer collaborations are growing significantly in both number and scope. The studies we’re developing and supporting are demonstrating that novel approaches to measuring and health can dramatically transform the way new treatments are delivered to patients.
Pensacola, FL – Nov 15, 2016 - ActiGraph, a leading provider of clinical-grade wearable activity and sleep monitoring solutions, has announced the launch of the CentrePoint technology toolkit, which enables clients to leverage the company’s ecosystem of hardware and software tools in the development of proprietary remote patient monitoring (RPM) systems and other home healthcare delivery solutions.
This week’s news that Takeda Pharmaceuticals inked a deal with Koneksa Health, a digital health startup that uses wearables and connected devices to gather patient data, reinforces the point that pharma companies have found a place for digital health tools in drug development. Koneksa Health CEO Chris Benko said he views the natural place for the use of these technologies in clinical studies either in early phases or as an exploratory addition in later phases in a phone interview with MedCity News.